IN DNA INDENA

Serial Number 79285579
Registration 6311375
700

Registration Progress

Application Filed
Mar 19, 2020
Under Examination
Approved for Publication
Jan 19, 2021
Published for Opposition
Jan 19, 2021
Registered
Apr 6, 2021

Trademark Image

IN DNA INDENA

Basic Information

Serial Number
79285579
Registration Number
6311375
Filing Date
March 19, 2020
Registration Date
April 6, 2021
Published for Opposition
January 19, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 6, 2021
Registration
Registered
Classes
003 005

Rights Holder

INDENA S.p.A

35
Address
Viale Ortles 12
I-20139 Milano
IT

Ownership History

INDENA S.p.A

Original Applicant
35
IT

INDENA S.p.A

Owner at Publication
35
IT

INDENA S.p.A

Original Registrant
35
IT

Legal Representation

Attorney
Stewart J. Bellus

USPTO Deadlines

Next Deadline
527 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-06)
Due Date
April 06, 2027
Grace Period Ends
October 06, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
May 27, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 14, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 1, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 27, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 14, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 22, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 22, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 17, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jul 6, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 6, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 24, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 19, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 19, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 30, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 30, 2020 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Dec 30, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 16, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 5, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 5, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 14, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 17, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 17, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 13, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 10, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 22, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 15, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
May 14, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 003
Cosmetics
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Pharmaceuticals for treating metabolic diseases, cardiovascular apparatus diseases, gastroenteric apparatus diseases, respiratory apparatus diseases, painful conditions, inflammatory diseases, diseases of the central and peripheral nervous system, eye diseases, diseases of the musculoskeletal apparatus, phonetic and olfactory apparatus diseases; Pharmaceutical preparations and substances for treating metabolic diseases, cardiovascular apparatus diseases, gastroenteric apparatus diseases, respiratory apparatus diseases, painful conditions, inflammatory diseases, diseases of the central and peripheral nervous system, eye diseases, diseases of the musculoskeletal apparatus, phonetic and olfactory apparatus diseases; Dietary supplements; Dietetic preparations adapted for medical purposes; Medicinal plant and herb extracts for use in the manufacture of / sold as components of medical preparations, pharmaceutical preparations and for use in the preparation of food supplements
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the stylized wording "IN" over the stylized wording "DNA", all over the design of a rhombus within outlining joined to a partial incomplete rectangle to the left of the stylized wording "INDENA", all within the design of four chevrons, one in each corner.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
003 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DNA"